Participated · Series A · Jan 2026

Snout provides veterinary clinics with a prevention-first financing platform that bundles routine services—such as unlimited exams, vaccinations, bloodwork, and flea-and-tick prevention—into affordable monthly wellness plans. By removing credit checks, age or breed discrimination, and reimbursement delays, the company enables more pets to receive essential care while reducing administrative burden for clinics. The platform is already available to millions of pets nationwide, giving veterinarians a modern financial infrastructure that lets them focus on medicine rather than billing. With new capital in hand, Snout plans to expand its national network of clinic partners, deepen operational support for veterinary teams, and enhance the pet-owner experience to drive long-term cost savings. Founded by CEO Emily Dong, the company positions itself as the first financing solution built specifically for preventive veterinary care at scale. Its model relies on interest-free payment plans that convert large upfront costs into manageable monthly fees, helping pet parents avoid difficult medical decisions based on cash constraints. Snout’s strategy is to build a comprehensive, prevention-focused ecosystem that keeps pets healthier and clinics more efficient.

Participated · Seed · Sep 2025

Parento offers a three-in-one paid parental leave solution that bundles customizable parental leave insurance, parental leave management services, and personalized one-on-one parent coaching. Its insurance product can provide up to 100% financial coverage and converts unpredictable leave costs into predictable premiums for small and mid-sized employers. The company reports strong outcomes: 95% of Parento parents return to work after leave, 10% average engagement rates for its coaching services, and 46% of claims were filed by men with up to 33% of men using one-on-one coaching. Parento serves diverse industries—25% of clients are in nonprofit or manufacturing/warehousing—and works with professional services, healthcare, law firms, nonprofits, and municipal organizations. Partnerships include the International Union of Operating Engineers (enabling first international expansion into Canada) and PEOs including one that serves more than half a million clients. Parento will use new capital to expand product development, sales, and marketing while launching additional insurance offerings and new products.

Participated · Seed · Jun 2025

VoiceCare AI builds agentic, voice-based AI to automate long, complex back-office healthcare workflows and reduce administrative burden. Its flagship voice AI agent, Joy, has been deployed across payer communication processes including benefits verification, prior authorizations, and claims management. The platform is HIPAA-compliant and SOC 2 Type II attested, and includes a proprietary Evaluation Framework (VC-Eval) and a simulation engine to validate accuracy and stress-test performance. VoiceCare emphasizes a "zero-skip, hallucination-free" architecture designed to prevent omitted or misrouted communications and ensure context-bound, verifiable responses. The company emerged from stealth earlier this year and plans to scale operations, enhance platform intelligence, accelerate product development, and expand engineering and go-to-market teams. VoiceCare AI has raised $4.54 million in seed funding to support those efforts. VoiceCare AI offers an agentic, multimodal voice AI platform—branded as "Joy"—designed to automate long, complex healthcare back-office conversations such as benefits verification, prior authorizations, and claims follow-ups. The system uses reinforcement learning from human feedback (RLHF) and proprietary conversational data and is HIPAA compliant and SOC 2 Type II attested. The company says its platform achieves a near-perfect call completion accuracy rate with a majority of calls completed autonomously, and provides detailed documentation and near real-time status updates to integrate with existing workflows. VoiceCare positions its product as a solution to large administrative burdens in U.S. healthcare (citing McKinsey estimates that administration accounts for $1 trillion of spend and that administrators spend 60–80% of time on insurance- and billing-related tasks). The team has assembled an advisory board with healthcare and AI expertise and is running a pilot with Mayo Clinic across neurology, pediatrics, and medical/administrative support operations. Funding will be used to expand the team, boost sales and marketing, and further invest in platform accuracy, security, and compliance.

Led · Seed · Mar 2025

Nimblemind.ai provides an AI-powered data infrastructure platform that curates and labels clinical datasets so healthcare providers can transform unstructured patient data into structured, AI-ready formats. The company’s proprietary approach ingests data from EMRs, patient surveys, and wearable devices and enables clinicians to generate decision-support insights and predictive analytics while preserving data sovereignty and compliance. Nimblemind.ai has secured partnerships with multiple healthcare organizations in the US and Asia to pilot and deploy its platform. With $2.5M in new funding, the company plans to expand specialty-specific AI models, enhance platform capabilities, and onboard more providers seeking AI-enabled care improvements. Leadership frames the product as foundational infrastructure to unlock AI’s potential in healthcare and create non-clinical revenue opportunities for providers.

Participated · Series A · Jan 2025

Delfina Care is a San Francisco-based healthcare technology company that applies AI-driven, evidence-based care to maternal and infant health. Led by CEO and founder Senan Ebrahim, MD, PhD, the company partners with diverse healthcare providers to deploy its care model. Delfina’s approach has produced measurable reductions in preterm births, NICU admissions, hypertensive disorders, and gestational diabetes among its partners’ populations. Its core product combines AI technology with provider partnerships to identify and manage high-risk pregnancies and improve outcomes. The company plans to use new funding to support national expansion, further innovate its AI technology, and deepen partnerships with healthcare providers. Financial and operating metrics such as revenue or user counts were not disclosed in the article.